Ropivacaine Hydrochloride
Who holds supplier records for Ropivacaine Hydrochloride? 15 organisations hold a current record for Ropivacaine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6), China (2), Italy (1), South Africa (1) and 4 other countries (4); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Ropivacaine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ropivacaine-hydrochloride
Reading the evidence
- 15 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 6 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (15)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Ropivacaine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Dishman Carbogen Amcis LimitedIndiaCEPActive DMF 22023, 25506 · latest filing Nov 2011
- EDMOND PHARMAItalyCEP Company GMP cert on recordActive DMF 35401 · latest filing Dec 2020
- Emcure Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 30217 · latest filing Feb 2016
- Fine Chemicals Corporation (PTY) Ltd.South AfricaCEP Company GMP cert on recordActive DMF 20654 · latest filing Jul 2007
- NAVINTA LLCUnited StatesCEPActive DMF 30152 · latest filing Sept 2016
- Shandong Anhong Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 25378 · latest filing Sept 2011
- Apex Healthcare LimitedIndiaActive DMF 42481 · latest filing Dec 2025
- CHEMWERTH INCFranceCEPActive DMF 20249 · latest filing Feb 2007
- EXCELLA GMBH AND CO KGGermany Company GMP cert on recordActive DMF 18288 · latest filing Apr 2005
- JUBILANT BIOSYS LTDIndiaActive DMF 24948 · latest filing Oct 2011
- MOEHS IBERICA SLSpainActive DMF 35568 · latest filing Mar 2021
- FRESENIUS KABI ONCOLOGY LTDIndiaCEP Company GMP cert on recordInactive DMF 26650, 36233 · latest filing Oct 2021
- MAC CHEM PRODUCTS INDIA PVT LTDCEPInactive DMF 27027 · latest filing Apr 2013
- ChinaCEP
- PIONEER AGRO INDUSTRIES SANVIN LABORATORIES PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (11)
Certificates of Suitability on the EDQM register for Ropivacaine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 16 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| FRESENIUS KABI ONCOLOGY LIMITED Kalyani | IN | CEP 2021-130 - Rev 01 Ropivacaine hydrochloride monohydrate, Alternate process | Aug 2026 | — |
| DISHMAN CARBOGEN AMCIS LIMITED Ahmedabad | IN | CEP 2024-385 - Rev 00 Ropivacaine hydrochloride monohydrate | Jul 2026 | — |
| NAVINTA LLC Ewing | US | CEP 2025-463 - Rev 00 Ropivacaine hydrochloride monohydrate | Apr 2026 | — |
| EDMOND PHARMA S.R.L. Paderno Dugnano | IT | CEP 2007-342 - Rev 04 Ropivacaine hydrochloride monohydrate | Mar 2025 | Inspected Mar 2025 Italy |
| SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO., LTD. Dezhou City | CN | CEP 2023-148 - Rev 01 Ropivacaine hydrochloride monohydrate | Jan 2025 | — |
| EMCURE PHARMACEUTICALS LIMITED Pune | IN | CEP 2022-392 - Rev 00 Ropivacaine hydrochloride monohydrate | Oct 2024 | Inspected May 2023 Hungary, outside 3-year window |
| MAC CHEM PRODUCTS (INDIA) PVT. LTD. Mumbai | IN | CEP 2017-246 - Rev 02 Ropivacaine hydrochloride monohydrate | Jun 2024 | — |
| SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou City | CN | CEP 2011-270 - Rev 04 Ropivacaine hydrochloride monohydrate | May 2024 | Inspected Nov 2025 Greece |
| PIONEER AGRO INDUSTRIES SANVIN LABORATORIES PRIVATE LIMITED Mumbai | IN | CEP 2006-294 - Rev 03 Ropivacaine hydrochloride monohydrate | Oct 2023 | — |
| Chemwerth, Inc. Woodbridge | US | R0-CEP 2022-198 - Rev 00 Ropivacaine hydrochloride monohydrate | Aug 2023 | — |
| FINE CHEMICALS CORPORATION (PTY) LTD. Cape Town | ZA | R1-CEP 2007-236 - Rev 03 Ropivacaine hydrochloride monohydrate | Jan 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Ropivacaine Hydrochloride is a long-acting local anesthetic of the amide type. It is commonly used for nerve block, epidural, and intrathecal anesthesia.
Chemical identity
- IUPAC name
- N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide
- Canonical SMILES
- CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
- InChIKey
- ZKMNUMMKYBVTFN-UHFFFAOYSA-N
- Synonyms
- Naropin API, RefChem:824156, racemic ropivacaine, Bupivacaine Impurity 11, rac-ropivacaine, DL-ropivacaine, (+-)-ropivacaine, (+/-)-Ropivacaine, AC-6967, N-n-propylpipecolic acid-2,6-xylidide, ((-))-1-Propyl-2',6'-pipecoloxylidide
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Amide Local Anesthetic
- Physiologic effect
- Local Anesthesia
- Chemical structure
- Amides
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Ropivacaine Hydrochloride?
15 organisations hold an active US FDA Type II Drug Master File or a CEP for Ropivacaine Hydrochloride: Dishman Carbogen Amcis Limited (India), EDMOND PHARMA (Italy), Emcure Pharmaceuticals Limited (India), Fine Chemicals Corporation (PTY) Ltd. (South Africa), NAVINTA LLC (United States), Shandong Anhong Pharmaceutical Co., Ltd. (China), Apex Healthcare Limited (India) and CHEMWERTH INC (France), and 7 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Ropivacaine Hydrochloride Drug Master Files are active?
Dishman Carbogen Amcis Limited (DMF 22023, 25506), EDMOND PHARMA (DMF 35401), Emcure Pharmaceuticals Limited (DMF 30217), Fine Chemicals Corporation (PTY) Ltd. (DMF 20654), NAVINTA LLC (DMF 30152), Shandong Anhong Pharmaceutical Co., Ltd. (DMF 25378), Apex Healthcare Limited (DMF 42481) and CHEMWERTH INC (DMF 20249) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Ropivacaine Hydrochloride have a European Certificate of Suitability?
Yes. 11 organisations hold a valid CEP for Ropivacaine Hydrochloride on the EDQM register, including FRESENIUS KABI ONCOLOGY LIMITED Kalyani (IN), DISHMAN CARBOGEN AMCIS LIMITED Ahmedabad (IN), NAVINTA LLC Ewing (US), EDMOND PHARMA S.R.L. Paderno Dugnano (IT), SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO., LTD. Dezhou City (CN) and EMCURE PHARMACEUTICALS LIMITED Pune (IN) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Ropivacaine Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Ropivacaine Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.